Clarix Imaging
Melissa Nielsen is a Clinical Application Specialist at Clarix Imaging since June 2022, previously serving as a Clinical Sales Specialist at Perfusio and HyperMed Imaging, Inc. from September 2020 to July 2022 and February 2018 to March 2020, respectively. Expertise includes training, business development, and hyperspectral imaging. Earlier roles include Women's Imaging Sales and Marketing Specialist and Lead Diagnostic Medical Sonographer, with a strong focus on client education and revenue growth. Nielsen's educational background includes institutions such as Sanford-Brown College-Dallas and the University of Arkansas, with a foundation in diagnostic imaging and sonography.
This person is not in any teams
Clarix Imaging
Clarix Imaging brings unprecedented clarity to intraoperative breast cancer lumpectomy margin visualization with our true 3D (CT) VSI-360™ Volumetric Specimen Imaging System. This advanced imaging technology takes breast surgeons and radiologists on a Journey Through the Specimen™ with views of any tissue slice from multiple angles – with no obscuring of the margins. Clarix Imaging is the only company to commercially offer a CT breast specimen imaging system. A venture-backed private company founded by world-renowned medical imaging scientists from the University of Chicago, Clarix Imaging’s mission is to empower clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine based on breakthrough innovations in imaging science and AI. Our first product is the FDA cleared true 3D VSI-360™, which offers radiologists and surgeons unprecedented clarity for intraoperative specimen margin visualization in breast cancer surgeries such as lumpectomy – right inside the operating room. VSI-360™ generates a true 3D image of the specimen in real-time, and its advanced software tools allow users to visualize the tumor in thin image slices without overlapping tissues obscuring the margins. Partner with us on our journey to advance outcomes in surgical oncology through innovations in imaging.